1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets.

Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added to it rapidly. As a result we have used some filters to select a few names for a detailed coverage in our Outlook this year.

Key Criteria for Our Selection are:
- Uniqueness of the Technology platform and the ability to scale up commercially in case of positive outcome of products in the pipeline
- Pipeline and clinical data analysis
- Marketed product and commercial tie up. Robustness of the Management, financial and business model.

Table Of Contents

Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets.
Part 1- Rising Stars in Regenerative Medicine and Stem cell based Cell Therapies-Drugs of the Future

Company Analysis:
CESCA Therapeutics Inc. : Hedging the Risk with Stem Cell Based Devices and Therapies and Global Presence
- Figure 1: Products In Pipeline
- Table 1: Clinical Development- Critical Limb Ischemia (ClI)Data Key Milestones
Ocata Therapeutics Inc: Ophthalmic Focus- Macular degenerative conditions- Looking with a New Eye
- Figure 1: Market For Age-Related Macular Degeneration (AMD)
- Figure 2: Products In The Pipeline
Orgenesis: Focus- Diabetes- Tricking your Liver to Make Insulin!
- Technology Platform
- Figure 1: Schematic Representation Of Making Autologous Insulin Producing (AIP) Cell
Tigenix NV : Exploiting the Adipose Tissue- Multiple Applications of Fat?
- Technology Platform
- Marketed Products
- Figure 1 : Products In Pipeline
- Key Milestones
Pluristem Therapeutics Inc: Regenerating and Recycling- Allogenic Therapies from the Placenta
- PluriX 3D Technology Platform
- Pipeline
- Figure 1 : Classification Of Peripheral Arterial Disease Types
- Market Opportunity
- Key Milestones
Mesoblast: Leader in Regenerative Sapce in Korea- Focusing on International Markets
- Technology Platform
- Pipeline- Focus on four major areas
- Figure 1: Drugs In The Pipeline
- Figure 2 : CHFf Discease Classification And Target Patients In PhIII Trial
- Figure 3: PhiII Data Of MPC-150 In CHF
- Figure 4 : Market Opportunity In Chronic Low Back Pain (CLBP)
- Key Milestones
Medipost Co Ltd : Leader in Regenerative Space in Korea- Focusing on International Markets
- Marketed and Products in the Pipeline
- Key Milestones
- Figure 1: Sales By Business Segment

JCR Pharmaceuticals co. Ltd.: First Stem Cell Based Product in Japan for Graft-Versus-Host Disease (GVHD).
- Technology Platform
- Product in the Pipeline
- Key Milestones
- Facts and Financials
- Table 1 : Pipeline Table
- Figure 1: Sales By Business Segments
Japan Tissue Engineering co. Ltd: Building Confidence in Regenerative Medicine- Fuji film Venture from Colors to Regenerative Medicine-
- Plat form Focus
- Products
- Figure 1 : Therapy and Product Focus


Part II-Indian Innovators- Rising Stars:
- Table 1: Select new generation innovation /drug discovery Indian companies
Connexios: Maturing Pipeline and Focus on Diabetes/Metabolic Disorders to Drive Visibility
- Technology Platform
- Therapy Focus—Diabetes/Metabolic Disorder and Non Alcoholic Steatohepatitis (NASH)
- Key Milestones
- Table 1: Differences Between G-Protein Coupled Receptor Agonists
- Table 2: Pipeline Of GPR Agonist For Treatment Of Type 2 Diabetes
- Figure 1: Products In Pipeline- Diabetes
- Figure 2: Products In Pipeline For NASH
- Figure 3: Other Programs
Cellworks : In silico Technology Platform Poised to Deliver- Focus on Personalised Medicine and Cancer
- Figure 1 : Simulation Based Personalized Medicine
- Figure 2 : Cellworks Therapeutic Programs
Bugworks: In silico Technology platform being applied to Serious Hospital Infections- Need of the hour!
- Therapy focus- Serious Hospital Infection
- Technology Platform
- Figure 1: Drug Development Success For TB
- Figure 2 : Going Way Froward
Tergene : Affordable and Second Generation Vaccines- Addressing the Urgent needs of Emerging Markets.
- Development Strategy and Status
- Figure 1: Sales Of Currently Available Vaccines For Streptococcus Pneumonia
- Figure 2: WW Demand Forecast Of Vaccines For Streptococcus Pneumonia
- Figure 3: Vaccine Market

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
OpportunityAnalyzer: Hyperparathyroidism - Opportunity Analysis and Forecasts to 2025

OpportunityAnalyzer: Hyperparathyroidism - Opportunity Analysis and Forecasts to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

OpportunityAnalyzer: Hyperparathyroidism - Opportunity Analysis and Forecasts to 2025 Summary Hyperparathyroidism (HPT) is a common endocrinal disorder characterized by excessive plasma levels of parathyroid ...

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Human Epidermal growth factor Receptor type 2 (HER2-) breast cancer is the second ...

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary Hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections ...


Download Unlimited Documents from Trusted Public Sources

Related Market Segments :

Therapy

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.